Unveiling the HER2-low phenomenon: exploring immunohistochemistry and gene expression to characterise HR-positive HER2-negative early breast cancerM. Gaudio, A. Zambelli, R. Gerosa et al.|Breast Cancer Research and Treatment|2023Cited by 9
53P HER2 low by immunohistochemistry (IHC) and gene expression by qRT-PCR using OncotypeDX in ER+ early breast cancerM. Gaudio, A. Zambelli, F. Jacobs et al.|ESMO Open|2023Cited by 1